New! Hire Essay Assignment Writer Online and Get Flat 20% Discount!!Order Now
POPH90111
AU
The University of Melbourne
As a genetic epidemiologist, you decide to conduct a genome-wide association study for a disease called Machotic disease. The study includes 2,000 people with Machotic disease (cases) and 2,000 people without Machotic disease (controls). The cases and controls are frequency matched for age, sex and ethnicity i.e., the cases, on average, are the same age, have the same proportion of each sex, and the same proportion of ethnicities as the controls. You obtain the following genotype results of 3 of the 500,000 SNPs tested.
SNP and genotype | Number of Cases | Number of Controls |
rs191 GG |
1100 |
1210 |
GA | 780 | 690 |
AA | 120 | 100 |
rs192 |
|
|
TT | 1440 | 1406 |
TC | 488 | 532 |
CC | 72 | 62 |
rs193 |
|
|
CC | 1160 | 1144 |
AC | 712 | 746 |
AA | 128 | 110 |
Estomagosis is a gastrointestinal disorder resulting in frequent abdominal pain, discomfort and constipation. The disease’s causes are not well known but a proportion of the disease is known to be caused by an inherited mutation in the gene AK19. Some studies reported smoking and fruit intake are also associated with Estomagosis. As a genetic epidemiologist, you decide to conduct a case-control study to investigate gene and environmental interactions associated with Estomagosis. The study includes 400 people with Estomagosis (cases) and 390 people without Estomagosis (controls). You genotype AK19 mutation in both cases and controls and survey them for long-term smoking, and if they regularly take fruits. You obtain the following results.
AK19 mutation | Long-term smoker | Estomagosis Present | Estomagosis Absent |
No | No | 280 | 320 |
No | Yes | 30 | 20 |
Yes | No | 60 | 40 |
Yes | Yes | 30 | 10 |
AK19 mutation | Regular fruit intake | Estomagosis Present | Estomagosis Absent |
No | No | 295 | 300 |
No | Yes | 15 | 40 |
Yes | No | 58 | 34 |
Yes | Yes | 32 | 16 |
Pulmon’s disease is a potentially fatal respiratory condition. The only cause of Pulmon’s disease is a genetic mutation in the SCD gene. Approximately 1 in 3,000 people carry this mutation. For people with a mutation in the SCD gene, the probability of dying from Pulmon’s disease is 20% if it is not treated before symptoms begin. Risk of dying from Pulmon’s disease can be reduced by 80% if carriers of a mutation in the SCD gene are given a single dose of a newly developed drug called Shyaceptin, before symptoms begin.
15,000+ happy customers and counting!